| |
| |
|
| Insider
Information: |
Mpm Oncology Impact Management Gp Llc |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
7,269,404 |
|
|
Indirect Shares
|
12,676,551 |
|
|
| Direct
Value |
$8,473,463 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
19,945,955 |
|
|
| Total
Value |
$8,473,463 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Harpoon Therapeutics, Inc. |
HARP |
10% Owner |
2019-02-12 |
3,898,422 |
2019-02-12 |
0 |
Premium* |
|
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2019-02-19 |
3,370,982 |
2019-02-19 |
0 |
Premium* |
|
|
Iteos Therapeutics, Inc. |
ITOS |
10% Owner |
2021-04-07 |
0 |
2021-04-09 |
6,004,368 |
Premium* |
|
|
Werewolf Therapeutics, Inc. |
HOWL |
10% Owner |
|
0 |
2021-05-04 |
6,672,183 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HOWL |
Werewolf Therapeutics, In... |
10% Owner |
– – • |
2021-05-04 |
4 |
B |
$16.00 |
$3,920,000 |
I/I |
245,000 |
6,672,183 |
1.5 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
10% Owner |
– – • |
2021-05-04 |
4 |
A |
$0.00 |
$0 |
I/I |
5,965,775 |
6,427,183 |
0 |
- |
|
| HOWL |
Werewolf Therapeutics, In... |
10% Owner |
– – • |
2021-04-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
461,408 |
|
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-04-09 |
4 |
AS |
$29.99 |
$5,998 |
I/I |
(200) |
6,004,368 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-04-08 |
4 |
AS |
$30.51 |
$985,802 |
I/I |
(32,304) |
6,004,568 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-04-07 |
4 |
AS |
$0.00 |
$0 |
I/I |
(15,670) |
6,036,872 |
0 |
- |
|
| ITOS |
Iteos Therapeutics, Inc. |
10% Owner |
– – • |
2021-04-07 |
4 |
AS |
$32.07 |
$315,048 |
I/I |
(9,678) |
6,052,542 |
0 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-02-19 |
4 |
B |
$15.00 |
$10,000,005 |
D/D |
666,667 |
3,370,982 |
2.45 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2019-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,704,315 |
2,704,315 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
– – • |
2019-02-12 |
4 |
B |
$14.00 |
$3,500,000 |
D/D |
250,000 |
3,898,422 |
2.45 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
– – • |
2019-02-12 |
4 |
S |
$14.00 |
$6,258 |
D/D |
(447) |
3,648,422 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
– – • |
2019-02-12 |
4 |
OE |
$0.05 |
$6,253 |
D/D |
127,096 |
3,648,869 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
10% Owner |
– – • |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,521,773 |
3,521,773 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
